BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
23 results:

  • 1. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.
    Chiriches C; Nicolaisen N; Wieske M; Elhaddad H; Mehmetbeyoglu E; Alvares C; Becher D; Hole P; Ottmann OG; Ruthardt M
    PLoS Genet; 2022 Oct; 18(10):e1010463. PubMed ID: 36288392
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. dek::AFF2 Fusion Carcinomas of Head and Neck.
    Ruangritchankul K; Sandison A
    Adv Anat Pathol; 2023 Mar; 30(2):86-94. PubMed ID: 36221219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD163 Immunohistochemical "Circle Sign" Staining Pattern Differentiates Sinonasal Papillomas From Morphologically Similar Non-neoplastic Lesions.
    Sterling BC; Mehrad M; Ely KA; Lewis JS
    Am J Surg Pathol; 2022 Nov; 46(11):1507-1513. PubMed ID: 35993580
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. In silico gene expression and pathway analysis of dek in the human brain across the lifespan.
    Greene AN; Nguyen ET; Paranjpe A; Lane A; Privette Vinnedge LM; Solomon MB
    Eur J Neurosci; 2022 Sep; 56(6):4720-4743. PubMed ID: 35972263
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. dek-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
    Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
    Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/dek-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
    Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S
    Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Middle Ear and Temporal bone Nonkeratinizing Squamous Cell Carcinomas With dek-AFF2 Fusion: An Emerging Entity.
    Todorovic E; Truong T; Eskander A; Lin V; Swanson D; Dickson BC; Weinreb I
    Am J Surg Pathol; 2020 Sep; 44(9):1244-1250. PubMed ID: 32366754
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);dek-NUP214 shows a favourable outcome when performed in first complete remission.
    Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A;
    Br J Haematol; 2020 Jun; 189(5):920-925. PubMed ID: 32020596
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The oncoprotein dek affects the outcome of PARP1/2 inhibition during mild replication stress.
    Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
    PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
    Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).
    Visconte V; Shetty S; Przychodzen B; Hirsch C; Bodo J; Maciejewski JP; Hsi ED; Rogers HJ
    Int J Lab Hematol; 2017 Aug; 39(4):409-417. PubMed ID: 28318095
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].
    Liu GM; Zhang LJ; Fu JZ; Liang WT; Cheng ZY; Bai P; Bian YS; Wan JS
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):140-145. PubMed ID: 28279039
    [No Abstract]    [Full Text] [Related]  

  • 13. The dek Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.
    Lohmann F; Dangeti M; Soni S; Chen X; Planutis A; Baron MH; Choi K; Bieker JJ
    Mol Cell Biol; 2015 Nov; 35(21):3726-38. PubMed ID: 26303528
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
    Mohamed AM; Balsat M; Thenoz M; Koering C; Payen-Gay L; Cheok M; Mortada H; Auboeuf D; Pinatel C; El-Hamri M; Dumontet C; Cros E; Flandrin-Gresta P; Nibourel O; Preudhomme C; Michallet M; Thomas X; Nicolini F; Solly F; Guyotat D; Campos L; Wattel E; Mortreux F
    Oncotarget; 2016 Jan; 7(3):2889-909. PubMed ID: 26284582
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. dek oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
    Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
    Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chromatin redistribution of the dek oncoprotein represses hTERT transcription in leukemias.
    Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
    Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Health resource utilization and cost associated with myeloproliferative neoplasms in a large United States health plan.
    Mehta J; Wang H; Fryzek JP; Iqbal SU; Mesa R
    Leuk Lymphoma; 2014 Oct; 55(10):2368-74. PubMed ID: 24450579
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
    Asleson AD; Morgan V; Smith S; Velagaleti GV
    Cancer Genet Cytogenet; 2010 Oct; 202(1):33-7. PubMed ID: 20804918
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies.
    Huang M; Li C; Liang H; Zhou J; Deng J; Liu W
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):661-3. PubMed ID: 17357482
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
    Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
    Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.